These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

544 related items for PubMed ID: 21454195

  • 21. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance.
    Kyle RA, Therneau TM, Rajkumar SV, Remstein ED, Offord JR, Larson DR, Plevak MF, Melton LJ.
    Blood; 2003 Nov 15; 102(10):3759-64. PubMed ID: 12881316
    [Abstract] [Full Text] [Related]

  • 22. A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders.
    Varettoni M, Zibellini S, Boveri E, Klersy C, Candido C, Rattotti S, Ferretti VV, Defrancesco I, Mangiacavalli S, Nizzoli ME, Flospergher E, Zerbi C, Bergamini F, Benvenuti P, Brociner M, Merati G, Paulli M, Arcaini L.
    Br J Haematol; 2019 Nov 15; 187(4):441-446. PubMed ID: 31276195
    [Abstract] [Full Text] [Related]

  • 23. Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors.
    Varettoni M, Zibellini S, Capello D, Arcaini L, Rossi D, Pascutto C, Rattotti S, Mangiacavalli S, Pochintesta L, Gotti M, Gaidano G, Cazzola M.
    Leuk Lymphoma; 2013 Nov 15; 54(11):2485-9. PubMed ID: 23442064
    [Abstract] [Full Text] [Related]

  • 24. Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemia.
    Tedeschi A, Conticello C, Rizzi R, Benevolo G, Laurenti L, Petrucci MT, Zaja F, Varettoni M.
    Hematol Oncol; 2019 Apr 15; 37(2):117-128. PubMed ID: 30192023
    [Abstract] [Full Text] [Related]

  • 25. Differential diagnosis of Waldenstrom's macroglobulinemia and other B-cell disorders.
    Pangalis GA, Kyrtsonis MC, Kontopidou FN, Siakantaris MP, Dimopoulou MN, Vassilakopoulos TP, Tzenou T, Kokoris S, Dimitriadou E, Kalpadakis C, Tsalimalma K, Tsaftaridis P, Panayiotidis P, Angelopoulou MK.
    Clin Lymphoma; 2005 Mar 15; 5(4):235-40. PubMed ID: 15794855
    [Abstract] [Full Text] [Related]

  • 26. Survival in monoclonal gammopathy of undetermined significance and Waldenström macroglobulinemia.
    Kristinsson SY, Björkholm M, Landgren O.
    Clin Lymphoma Myeloma Leuk; 2013 Apr 15; 13(2):187-90. PubMed ID: 23490991
    [Abstract] [Full Text] [Related]

  • 27. Are neurological complications of monoclonal gammopathy of undetermined significance underestimated?
    Steiner N, Schwärzler A, Göbel G, Löscher W, Wanschitz J, Gunsilius E.
    Oncotarget; 2017 Jan 17; 8(3):5081-5091. PubMed ID: 27974705
    [Abstract] [Full Text] [Related]

  • 28. The clinical spectrum of IgM monoclonal gammopathy: A single center retrospective study of 377 patients.
    Cao XX, Meng Q, Mao YY, Su W, Zhen JF, Shen KN, Zhang CL, Huang XF, Duan MH, Zhang W, Zhu TN, Cai HC, Chen M, Zhou DB, Li J.
    Leuk Res; 2016 Jul 17; 46():85-8. PubMed ID: 27232065
    [Abstract] [Full Text] [Related]

  • 29. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
    Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y, Sheehy P, Manning RJ, Patterson CJ, Tripsas C, Arcaini L, Pinkus GS, Rodig SJ, Sohani AR, Harris NL, Laramie JM, Skifter DA, Lincoln SE, Hunter ZR.
    N Engl J Med; 2012 Aug 30; 367(9):826-33. PubMed ID: 22931316
    [Abstract] [Full Text] [Related]

  • 30. [Monoclonal gammopathy of undetermined significance].
    Hermansen NEU, Silkjær T, Hansen CT, Aagaard TG, Gregersen H.
    Ugeskr Laeger; 2020 Mar 02; 182(10):. PubMed ID: 32138824
    [Abstract] [Full Text] [Related]

  • 31. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
    Naina HV, Harris S, Dispenzieri A, Cosio FG, Habermann TM, Stegall MD, Dean PG, Prieto M, Kyle RA, Rajkumar SV, Leung N.
    Am J Nephrol; 2012 Mar 02; 35(4):365-71. PubMed ID: 22473253
    [Abstract] [Full Text] [Related]

  • 32. Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Kyle RA, Treon SP, Alexanian R, Barlogie B, Björkholm M, Dhodapkar M, Lister TA, Merlini G, Morel P, Stone M, Branagan AR, Leblond V.
    Semin Oncol; 2003 Apr 02; 30(2):116-20. PubMed ID: 12720119
    [Abstract] [Full Text] [Related]

  • 33. Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms.
    Varettoni M, Arcaini L, Zibellini S, Boveri E, Rattotti S, Riboni R, Corso A, Orlandi E, Bonfichi M, Gotti M, Pascutto C, Mangiacavalli S, Croci G, Fiaccadori V, Morello L, Guerrera ML, Paulli M, Cazzola M.
    Blood; 2013 Mar 28; 121(13):2522-8. PubMed ID: 23355535
    [Abstract] [Full Text] [Related]

  • 34. Unraveling the heterogeneity of IgM monoclonal gammopathies: a gene mutational and gene expression study.
    Jiménez C, Prieto-Conde MI, García-Álvarez M, Alcoceba M, Escalante F, Chillón MDC, García de Coca A, Balanzategui A, Cantalapiedra A, Aguilar C, Corral R, González-López T, Marín LA, Bárez A, Puig N, García-Mateo A, Gutiérrez NC, Sarasquete ME, González M, García-Sanz R.
    Ann Hematol; 2018 Mar 28; 97(3):475-484. PubMed ID: 29353304
    [Abstract] [Full Text] [Related]

  • 35. Primary systemic amyloidosis: a rare complication of immunoglobulin M monoclonal gammopathies and Waldenström's macroglobulinemia.
    Gertz MA, Kyle RA, Noel P.
    J Clin Oncol; 1993 May 28; 11(5):914-20. PubMed ID: 8487054
    [Abstract] [Full Text] [Related]

  • 36. Prognostic factors and predictors of outcome of immunoglobulin M monoclonal gammopathy of undetermined significance.
    Kyle RA, Rajkumar SV, Therneau TM, Larson DR, Plevak MF, Melton LJ.
    Clin Lymphoma; 2005 Mar 28; 5(4):257-60. PubMed ID: 15794860
    [Abstract] [Full Text] [Related]

  • 37. Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenström's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance.
    Martín-Jiménez P, García-Sanz R, Balanzategui A, Alcoceba M, Ocio E, Sanchez ML, González M, San Miguel J.
    Haematologica; 2007 May 28; 92(5):635-42. PubMed ID: 17488687
    [Abstract] [Full Text] [Related]

  • 38. The spectrum of IgM monoclonal gammopathy in 430 cases.
    Kyle RA, Garton JP.
    Mayo Clin Proc; 1987 Aug 28; 62(8):719-31. PubMed ID: 3110508
    [Abstract] [Full Text] [Related]

  • 39. Predictive variables for malignant transformation in 452 patients with asymptomatic IgM monoclonal gammopathy.
    Morra E, Cesana C, Klersy C, Varettoni M, Cavanna L, Canesi B, Tresoldi E, Barbarano L, Lazzarino M, Hematology/Oncology Studies and Trials (HOST) Group, Italy.
    Semin Oncol; 2003 Apr 28; 30(2):172-7. PubMed ID: 12720131
    [Abstract] [Full Text] [Related]

  • 40. Prognostic factors and indications for treatment of Waldenström's Macroglobulinemia.
    Kyle RA, Ansell SM, Kapoor P.
    Best Pract Res Clin Haematol; 2016 Jun 28; 29(2):179-186. PubMed ID: 27825464
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.